Tang Capital’s Concentra back with another buyout offer, this time for LianBio

Tang Capital’s Concentra back with another buyout offer, this time for LianBio

Source: 
Fierce Biotech
News Tags: 
snippet: 

Tang Capital Partners’ Concentra Biosciences is back with yet another biotech buyout offer, this time proposing to acquire LianBio in a cash deal of $4.30 per share.